IP Library Granted Patent US 12,653,940
Granted Patent B2
US 12,653,940 · App. 17/292,979 · Granted Jun 16, 2026

Wound therapy system with blockage and leak detection

Inventors: Benjamin A. Pratt (Wimborne, GB); Justin Rice (San Antonio, TX)
Assignee: Solventum Intellectual Properties Company
A61M1/742A61M1/74A61M1/96A61M1/962A61M1/98A61M1/982A61M1/92A61M2205/15A61M2205/18A61M2205/3344
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 12,653,940
App. No.
17/292,979
Granted
Jun 16, 2026
Kind
B2
Abstract

A wound therapy system includes a single conduit fluidly connecting a wound site to a. removed fluid canister. A negative pressure circuit is defined by the wound site, the conduit, the removed fluid canister and tubing extending between the removed fluid canister and a pneumatic pump that applies negative pressure to the negative pressure circuit. A method of operating the wound therapy system includes profiling and benchmarking pressure decay within the negative pressure circuit against previous and/or expected pressure decay to identify any new or sudden anomalies that occur during the operation of the wound therapy system. The wound therapy system may additionally alert a user to such anomalous operation of the wound therapy system and/or identify and alert a user to an underlying cause (e.g, blockage and/or leak, etc.) that is responsible for the anomalous readings.

Claims (28)

1 . A wound therapy system comprising:

a canister configured to contain fluid removed from a wound site;

a conduit having a first end coupled to the canister and a second end operably coupled to the wound site, wherein an interior volume of the conduit is defined by a single lumen providing the only fluid path to the wound site;

wherein an interior volume of the canister and the interior volume of the conduit define a negative pressure circuit;

a pump fluidly operably coupled to the wound site via the conduit and configured to apply negative pressure to the wound site via the negative pressure circuit;

a pressure indicator configured to indicate a pressure within the negative pressure circuit; and

a controller configured to:

store a baseline pressure decay curve from an external model including an estimated volume and leak rate equal to the negative pressure circuit and that is representative of an expected change in pressure within the negative pressure circuit from a first negative pressure to a predetermined threshold pressure over a first period of time;

generate a second pressure decay curve by operating the pump to apply a second applied negative pressure equal to the first negative pressure to the negative pressure circuit and measuring a change in pressure over a second period of time within the negative pressure circuit during which the pressure within the negative pressure circuit increases from the second applied negative pressure to the threshold pressure;

compare the second pressure decay curve to the baseline pressure decay curve; and

generate an alert in response to detecting that a difference between the second pressure decay curve and the baseline pressure decay curve exceeds a predetermined first variance threshold.

2 . The wound therapy system of claim 1 , wherein, in response to generating the alert, the controller is further configured to:

generate a third pressure decay curve by operating the pump to apply a third applied negative pressure equal to the first negative pressure to the negative pressure circuit and measuring a change in pressure over a third time period within the negative pressure circuit during which the pressure within the negative pressure circuit increases from the third applied negative pressure to the threshold pressure; and

compare the third pressure decay curve to the second pressure decay curve.

3 . The wound therapy system of claim 2 , wherein the controller is further configured to generate a blockage alarm in response to detecting that the third pressure decay curve is substantially the same as the second pressure decay curve.

4 . The wound therapy system of claim 2 , wherein the controller is further configured to generate a leakage alarm in response to detecting that a difference between the third pressure decay curve and the second pressure decay curve exceeds a predetermined second variance threshold.

5 . The wound therapy system of claim 1 , wherein, in response to detecting that the second pressure decay curve is substantially the same as the baseline pressure decay curve, the controller is further configured to, following a predetermined time interval:

generate a third pressure decay curve by operating the pump to apply a third applied negative pressure equal to the first negative pressure to the negative pressure circuit and measuring a change in pressure over a third time period within the negative pressure circuit during which the pressure within the negative pressure circuit increases from the third applied negative pressure to the threshold pressure; and

compare the third pressure decay curve to the baseline pressure decay curve.

6 . The wound therapy system of claim 1 , wherein the baseline pressure decay curve is one of a plurality of baseline pressure decay curves stored by the controller, the controller further comprising a second baseline pressure decay curve generated based on measuring pressure decay within the negative pressure circuit prior to an initial use of the wound therapy system to provide negative pressure therapy to the wound site.

7 . The wound therapy system of claim 1 , further comprising a calibrated leak in fluid communication with the negative pressure circuit, the calibrated leak configured to allow ambient air to flow into the negative pressure circuit at a known flow rate and increase in pressure within the negative pressure circuit.

8 . The wound therapy system of claim 1 , wherein the detected difference between the second pressure decay curve and the baseline pressure decay curve comprises at least one of a difference between a slope of the baseline pressure decay curve and a slope of the second pressure decay curve and a difference between the first period of the time and the second period of time.

9 . The wound therapy system of claim 8 , wherein the first variance threshold is between approximately 5% and approximately 15%.

10 . The wound therapy system of claim 4 , wherein the detected difference between the third pressure decay curve and the second pressure decay curve comprises at least one of a difference between a slope of the third pressure decay curve and a slope of the second pressure decay curve and a difference between the third period of the time and the second period of time.

11 . The wound therapy system of claim 4 , wherein the detected difference between the second pressure decay curve and the baseline pressure decay curve comprises at least one of a difference between a slope of the baseline pressure decay curve and a slope of the second pressure decay curve and a difference between the first period of the time and the second period of time.

12 . The wound therapy system of claim 1 , wherein the baseline pressure decay curve stored by the controller comprises a plurality of volume-specific baseline pressure decay curves, each of the volume-specific baseline pressure decay curves being representative of a change in pressure within a negative pressure circuit defined by a specific volume; the controller further being configured to determine a volume of the negative pressure circuit, wherein the baseline pressure decay curve to which the second decay curve is compared comprises a volume-specific baseline pressure decay curve corresponding to the determined volume of the negative pressure circuit.

13 . The wound therapy system of claim 12 , wherein the volume of the negative pressure circuit is determined based on an identification by the controller of the interior volume of the canister.

14 . The wound therapy system of claim 13 , wherein the volume of the negative pressure circuit is further determined based on an identification by the controller of an amount of fluid that has been instilled to the wound site.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 1, 2024
From: 3M INNOVATIVE PROPERTIES COMPANY
To: SOLVENTUM INTELLECTUAL PROPERTIES COMPANY
Reel/Frame 066436/0225 →
CORRECTIVE ASSIGNMENT TO CORRECT THE APPLICATION LISTED ON SCHEDULE OF IP RIGHTS ATTACHED TO ASSIGNMENT AT LINES 55: 71; 89; 116-129; AND 131 NEED TO BE DELETED PREVIOUSLY RECORDED AT REEL: 064788 FRAME: 0823. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. Recorded Sep 13, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064886/0479 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 31, 2023
From: KCI LICENSING, INC.
To: 3M INNOVATIVE PROPERTIES COMPANY
Reel/Frame 064788/0823 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded May 13, 2021
From: PRATT, BENJAMIN A.; RICE, JUSTIN
To: KCI LICENSING, INC.
Reel/Frame 056235/0965 →